-
Where Will Niraj Cement Structurals Share Price Be in the Next 3 Years?
- July 22, 2026
- Posted by: Ankit Jaiswal
- Category: News
No Comments
The Niraj Cement Structurals share price forecast for the next 3 years points to a scenario range of Rs 32 to Rs 52 by 2030, driven by rising demand for precast concrete products from infrastructure and construction clients and sector tailwinds.
-
NINtec Systems Share Price Outlook: Where Could It Be by 2030?
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
The NINtec Systems share price forecast for the next 3 years points to a scenario range of Rs 1,120 to Rs 1,890 by 2030, driven by rising enterprise IT infrastructure and networking demand and sector tailwinds.
-
NRB Industrial Bearings Share Price Outlook: Where Could It Be by 2030?
- July 22, 2026
- Posted by: Ankit Jaiswal
- Category: News
The NRB Industrial Bearings share price forecast for the next 3 years points to a scenario range of Rs 42 to Rs 69 by 2030, driven by rising industrial and auto demand for precision bearings and sector tailwinds.
-
Nitiraj Engineers Share Price Outlook: Where Could It Be by 2030?
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
The Nitiraj Engineers share price forecast for the next 3 years points to a scenario range of Rs 240 to Rs 395 by 2030, driven by rising industrial and municipal water treatment demand as environmental regulations tighten and sector tailwinds.
-
Chemplast Sanmar vs DCM Shriram Business Model: Which Chlor-Alkali Chemicals Wins
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
Chemplast Sanmar vs DCM Shriram business model compares concentrated chlor-alkali chemicals and specialty PVC resin manufacturing against diversified conglomerate spanning sugar, chlor-alkali chemicals and fertiliser to see which chlor-alkali chemicals has better business model.
-
Rainbow Children’s Medicare vs Apollo Hospitals Business Model: Which Hospitals Wins
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
Rainbow Children’s Medicare vs Apollo Hospitals business model compares concentrated pediatric and maternity specialty hospital network against largest private hospital chain with diversified healthcare ecosystem to see which hospitals has better business model.
-
Abakkus Small Cap Regular Growth: NAV Today, Performance Review and Should You Invest?
- July 22, 2026
- Posted by: Neeraj Pandey
- Category: Mutual Funds
Abakkus Small Cap Regular Growth NAV, latest returns and full review including risks and how to invest.
-
Akums Drugs and Pharmaceuticals vs Piramal Pharma Business Model: Which Pharma Contract Manufacturing Wins
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
Akums Drugs and Pharmaceuticals vs Piramal Pharma business model compares concentrated domestic contract manufacturing for branded generics against diversified CDMO, complex hospital generics and consumer healthcare to see which pharma contract manufacturing has better business model.
-
ABSL Banking & PSU Debt Direct Quarterly IDCW: NAV Today, Performance Review and Should You Invest?
- July 22, 2026
- Posted by: Neeraj Pandey
- Category: Mutual Funds
ABSL Banking & PSU Debt Direct Quarterly IDCW NAV, latest returns and full review including risks and how to invest.
-
Where Is NGL Fine-Chem Share Price Headed Over the Next 3 Years?
- July 22, 2026
- Posted by: Ankit Jaiswal
- Category: News
The NGL Fine-Chem share price forecast for the next 3 years points to a scenario range of Rs 3,860 to Rs 6,300 by 2030, driven by rising global demand for steroid based APIs and specialty pharmaceutical intermediates and sector tailwinds.